mk0767
Small moleculeexperimental
Clinical trial activity
10 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
10
Phase 3
8
Phase 4
0
Earliest trial started Oct 1, 2001 (NCT00543556)
Timeline
Indications
Mechanism of action
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- mk0767
- mk0767
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT00543816 | Phase 3 | Aug 1, 2003 | Merck |
| NCT00547274 | Phase 3 | Jul 1, 2003 | Merck |
| NCT00543738 | Phase 3 | Jun 1, 2003 | Merck |
| NCT00543361 | Phase 3 | May 1, 2003 | Merck |
| NCT00543491 | Phase 3 | May 1, 2003 | Merck |
| NCT00543517 | Phase 3 | Feb 1, 2003 | Merck |
| NCT00543751 | Phase 3 | Jan 1, 2003 | Merck |
| NCT00543010 | Phase 3 | Nov 1, 2002 | Merck |
| NCT00703690 | Phase 2 | Jan 1, 2002 | Merck |
| NCT00543556 | Phase 2 | Oct 1, 2001 | Merck |
Showing 10 of 10 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Merck | For profit | 10 | 10 | 2 | 2001 |
1 organizations
Page 1 / 1